Hematologic Oncology Update
by Dr. Neil Love
Novel Therapies for Non-Hodgkin Lymphoma — Microlearning Activity 1…
About this podcast
Featuring one-on-one interviews conducted by Dr Neil Love, this series provides medical oncologists with access to an array of important perspectives and information on relevant advances in the treatment of hematologic cancer to facilitate optimal patient care.
Episodes
The newest 20 of 172 episodes
- Novel Therapies for Non-Hodgkin Lymphoma — Microlearning Activity 1: An Interview with Dr Matthew Lunning on CNS Prophylaxis · 18 min · Season 26 Episode 110Featuring an interview with Dr Matthew Lunning, including the following topics: • A woman in her late 70s with non-GCB diffuse large B-cell lymphoma receives pola-R-CHP — Ann…
- Chronic Lymphocytic Leukemia — Rapid Case Review: Microlearning Activity 6 · 33 min · Season 26 Episode 109Featuring perspectives from Dr Lindsey Roeker, including the following topics: • Case: A man in his mid 60s with TP53-aberrant chronic lymphocytic leukemia (CLL) with extensive…
- Chronic Lymphocytic Leukemia — 5-Minute Journal Club: Microlearning Activity 5 · 26 min · Season 26 Episode 108Featuring perspectives from Dr Lindsey Roeker, including the following topics: • Consensus Approach to optimizing front-line treatment (0:00) • Emerging role of sonrotoclax…
- Non-Hodgkin Lymphoma — A Roundtable Discussion on CD20 x CD3 Bispecific Antibodies and the Optimal Management of Cytokine Release Syndrome · 1 h 58 min · Season 26 Episode 107Featuring perspectives from Dr Spencer Bachow, Dr Bhavana (Tina) Bhatnagar, Dr Jennifer Crombie, Dr Manali Kamdar and Ms Alexandra Lynch, co-moderated by Dr Bachow and Dr…
- Chronic Lymphocytic Leukemia — Microlearning Activity 2 · 28 min · Season 26 Episode 106Featuring perspectives from Dr Catherine C Coombs, including the following topics: • Phase III BRUIN CLL-322 trial of fixed-duration pirtobrutinib in combination with venetoclax…
- Chronic Lymphocytic Leukemia — Microlearning Activity 1 · 25 min · Season 26 Episode 105Featuring perspectives from Dr Catherine C Coombs, including the following topics: • Early versus delayed addition of obinutuzumab to acalabrutinib and venetoclax in…
- Relapsed/Refractory Multiple Myeloma — Proceedings from a Session Held During the Society of Hematologic Oncology 2026 Annual Meeting · 60 min · Season 26 Episode 104Featuring perspectives from Dr Meletios-Athanasios (Thanos) C Dimopoulos, Dr Robert Z Orlowski and Dr Noopur Raje, moderated by Dr Orlowski, including the following topics: •…
- Chronic Lymphocytic Leukemia — Investigators Discuss Optimal Management · 58 min · Season 26 Episode 103Featuring perspectives from Dr Catherine C Coombs and Dr Matthew S Davids, including the following topics: • Introduction (0:00) • Minimal Residual Disease Assays in…
- Diffuse Large B-Cell Lymphoma — An Interview with Dr L Elizabeth Budde on Employing CD20 x CD3 Bispecific Antibodies · 47 min · Season 26 Episode 102Featuring an interview with Dr L Elizabeth Budde, including the following topics: • Considerations for selecting between bispecific antibodies (BsAbs); monotherapy versus…
- Diffuse Large B-Cell Lymphoma — Proceedings from a Symposium Held in Conjunction with the American Oncology Network · 50 min · Season 26 Episode 101Featuring perspectives from Dr Ann LaCasce and Dr Stephen "Fred" Divers, moderated by Dr Divers, including the following topics: • Introduction (0:00) • First-Line Treatment…
- Chronic Lymphocytic Leukemia — Proceedings from a Symposium Held in Conjunction with the American Oncology Network · 54 min · Season 25 Episode 100Featuring perspectives from Dr Farrukh T Awan and Dr Stephen "Fred" Divers, moderated by Dr Divers, including the following topics: • Introduction (0:00) • First-Line Therapy…
- Non-Hodgkin Lymphoma and Chronic Lymphocytic Leukemia — Reviewing Recent Datasets from the 2026 ASCO Annual Meeting and EHA2026 Congress · 1 h 28 min · Season 25 Episode 99Featuring perspectives from Dr Brad S Kahl, Dr Jeff Sharman and Dr Tanya Siddiqi, including the following topics: • Introduction (0:00) • Trials in Progress (1:12) • Chronic…
- Antibody-Drug Conjugates for Multiple Myeloma — An Interview with Dr Douglas W Sborov · 50 min · Season 25 Episode 98Featuring an interview with Dr Douglas W Sborov, including the following topics: • DREAMM-2 trial outcomes and clinical development of antibody-drug conjugates for multiple…
- Chronic Myeloid Leukemia — An Interview with Prof Andreas Hochhaus · 60 min · Season 25 Episode 97Featuring an interview with Prof Andreas Hochhaus, including the following topics: • Biology of chronic myeloid leukemia (CML) and rationale for current therapeutic approaches…
- Chronic Lymphocytic Leukemia — Rapid Case Review: Microlearning Activity 4 · 31 min · Season 25 Episode 96Featuring perspectives from Prof John Seymour and cases from Dr Daniel Ermann, Dr Shazia Nakhoda and Dr Mahesh Swaminathan, including the following topics: • Case: A woman in…
- Chronic Lymphocytic Leukemia — 5-Minute Journal Club: Microlearning Activity 3 · 23 min · Season 25 Episode 95Featuring perspectives from Prof John Seymour, including the following topics: • Safety of fixed-duration acalabrutinib/venetoclax for chronic lymphocytic leukemia (CLL) (0:00)…
- Relapsed/Refractory Chronic Lymphocytic Leukemia — A Grand Rounds Program · 59 min · Season 25 Episode 94Featuring perspectives from Dr William G Wierda, including the following topics: • Introduction: Overview of the Grand Rounds Chronic Lymphocytic Leukemia Initiative (0:00) •…
- Non-Hodgkin Lymphoma — Year in Review Series on Relevant New Datasets and Advances · 1 h 0 min · Season 25 Episode 93Featuring perspectives from Dr Matthew Matasar and Dr Sonali M Smith, including the following topics: • Introduction: Lymphoma Survivorship (0:00) • Novel Treatment Approaches…
- Multiple Myeloma — Year in Review Series on Relevant New Datasets and Advances · 58 min · Season 25 Episode 92Featuring perspectives from Dr Amrita Krishnan and Dr Robert Z Orlowski, including the following topics: • Introduction (00:00) • Up-Front Progression-Free Survival for…
- Non-Hodgkin Lymphoma — Proceedings from a Session Held in Conjunction with the 2026 ASCO Annual Meeting on the Roles of CAR T-Cell Therapy and Bispecific Antibodies · 1 h 59 min · Season 25 Episode 91Featuring perspectives from Dr Jeremy S Abramson, Dr Joshua Brody, Dr Manali Kamdar, Dr Tycel Phillips and Dr Jason Westin, moderated by Dr Abramson, including the following…








